Skip to main content
Rameda
Microscopes and glassware on a bench in a bright Rameda laboratory

Our Facilities

Our Integrated Manufacturing Infrastructure

Production Facilities Overview

Rameda operates three fully independent factories at its plant in Cairo’s Sixth of October Industrial Zone. The purpose-built factories were designed by V-Konsult, a German engineering company, and built by British Carter Construction Ltd. In 2012, Rameda collaborated with M+W Process Industries GmbH, a global engineering and construction company offering complete process and facilities solutions for the pharmaceutical industry, to redesign the plant production areas and ensure GMP compliance.

A researcher in blue gloves holding a microplate above racked sample tubes
Red and yellow capsules moving along a production line
  • Over3Fully independent factories
  • Over40KsqmLand area
  • Over38KsqmBuilt-up area
  • Overc7KsqmDedicated production facility

Secure, Efficient, and Well-Managed Storage Facilities

Warehousing Facilities

Rameda has a state-of-the-art, purpose-built warehousing facility that includes the following:

  1. Climate-Controlled Storage Capacity

    General storage space spanning over 3,078 sqm of air-conditioned space, storing approximately 10,000 pallets.

  2. Dedicated Cephalosporin Storage

    1,650 sqm of storage space dedicated to housing cephalosporin products, with a total capacity of 1,600 pallets.

  3. Dedicated Penicillin Storage

    1,000 sqm of storage space dedicated to housing penicillin products, with a total capacity of over 1,510 pallets.

  4. Temperature-Controlled Storage

    Four fridges with temperatures set to 5 (± 3) degrees Celsius and one cool room set at 15 (± 3) degrees Celsius.

Three Standalone Factories

Production Lines

Rameda specializes in the manufacturing of human and veterinary pharmaceutical products. Its plant is comprised of three standalone factories located in the same industrial complex.

Eye Drops Production Area

Rameda began producing eye drops in 1998 and renovated its production area in 2013. In 2017, the Group added lidocaine preparation to the area. The eye drop production line occupies an area of 710 sqm with an annual production capacity of 16.3 million bottles.

A woman applying eye drops